A rare case report of HIV-associated nasopharyngeal carcinoma concurrent with local polymorphic B-cell lymphoproliferative disorder is reported and discussed on the ground of the most recent literature evidences. Only very few reports of nasopharyngeal carcinoma have been described until now in patients infected with HIV (one case in adults), and a coexisting lymphoid cell proliferation with a concurrent role of Epstein-Barr virus in prompting both disorders was never reported to date. The relevant pathogenetic, diagnostic, and therapeutic questions raised by this infrequent intriguing association retrieved in a patient with prominent HIV-related immunodeficiency are focused on.
Only two cellular types may become infected with Epstein-Barr virus (EBV) in humans: B lymphocytes and squamous epithelial cells, although some hypotheses have been claimed (but never confirmed) about the involvement of EBV in the development of other epithelial tumors, including breast and hepatocellular carcinoma. [1] [2] [3] This restricted EBV cell tropism is probably sustained by the common expression of the CD21 ligand, which acts as an active receptor for the C3d complement component, and also shares affinity for the surface receptors of EBV. [1] [2] [3] Moreover, different EBV BZLF1 gene variants seem to be expressed in specifically transformed cells, one being associated mainly with epithelial or squamous tumor cells and the other with lymphocytes, whereas multiple, different viral (EBV) strains have been detected in the same individual affected with cancer. 4 EBV is the causative agent of infectious mononucleosis, and it is etiologically linked with the development of nasopharyngeal carcinoma, as well as a broad spectrum of other illnesses, including lymphoproliferative disorders and lymphomas of the immunocompromised host, the chromosome X-linked lymphoproliferative disease, a chronic interstitial pneumonia of HIV-infected children, and the so-called oral "hairy cell" leukoplachia observed among HIV-infected patients. 2, 3 The extensive oncogenic potential of EBV is confirmed by its capability to lead to in vitro B lymphocyte transformation and immortalization, and to represent a causative agent of malignancies in primates, although these last tumors are more similar to immunodeficiency-associated lymphomas, rather than Burkitt lymphoma. Anyway, the majority of EBVassociated tumors are rare and occur at higher incidence only in certain geographic regions, so that environmental and genetic factors are involved in their pathogenesis. 2, 3 When considering the pathogenesis of Burkitt lymphoma and its predominantly African location, a possible supportive role of a concurrent malaria infection has been repeatedly suggested, on the ground of the geographical linkage between areas that are endemic for both diseases and the reduced frequency of Burkitt lymphoma observed where malaria eradication was achieved. 3, [5] [6] [7] When focusing our attention on nasopharyngeal carcinoma, it is a very different clinical entity compared with other head and neck cancers, because of its multifactorial etiology and its particular geographic distribution. 6 Nasopharyngeal carcinoma takes origin from the squamous epithelial nasopharyngeal cells, and its prevalence is particularly elevated in Southern China and other areas of Southeast Asia (such as Vietnam and Malaysia), and it proves more common in the male gender. 2, 6, 7 Regardless of their geographical localization, even 100% of sera coming from patients who developed an undifferentiated endemic nasopharingeal squamous cell cancer show high-titer (or a raising titer) of antibodies reactive against the early viral capsid antigen (VCA) antigen of EBV; some advantage has been observed in the specific search of IgA over IgG antibodies against VCA. 8 The association between nasopharyngeal carcinoma and EBV infection drops when sporadic, nonendemic, and welldifferentiated cases are considered. 3, [5] [6] [7] The retrieval of an EBV-encoded RNA signal and the quantification of serum EBV-DNA also seem strictly related to both disease stage and prognosis, 1,2,6-11 but a specific genetic background also seems to play a significant role in the pathogenesis of nasopharyngeal carcinoma, 6 as well as the disappearance of CD21 membrane receptor after the occurrence of EBV infection. 11 As anticipated, the malignant epithelial cells of biopsy specimens of nasopharyngeal carcinoma contain multiple copies of EBV genoma, as reliably ascertained by different laboratory techniques, such as in situ ibridization, immunohistochemical studies, and PCR assays, as well as the recognition of latent membrane oncogene deletions. 1, 6, 7, [9] [10] [11] The greater incidence of nasopharyngeal carcinoma observed in some selected areas of the world, the lower rate retrieved among Caucasians, and the intermediate frequency found among African and central-Asian populations 7 make probable that this malignancy may develop under genetically restricted conditions, 6, 11 but the role of environmental and dietary cofactors (consumption of salted fish, and soil and food contamination by phenolic esters) has been also postulated in the pathogenesis of this disorder in Southeast Asia, 6, 7, 11 together with the wellknown role of cigarette smoking on squamous epithelial cells of the entire respiratory tract.
A unique case report of EBV-related nasopharyngeal carcinoma concurrent with an EBV-related polymorphic B-cell lymphoproliferative disorder, is reported and discussed on the ground of the most recent literature evidences, and the pathogenetic, diagnostic, and therapeutic questions prompted by this intriguing association retrieved in the immunocompromised host.
Case Report
A 42-year-old cigarette-smoking male who abused both IV heroin and inhalatory cocaine had HIV infection detected since 1985, which was later associated with a chronic, concomitant hepatitis B virus and hepatitis C virus. Psychiatric comorbidity was concurrent, as well as chronic cholelithiasis and Paget disease; a brother was deceased because of AIDS. Because of a very poor adherence rate to the recommended antiretroviral therapy, his immunodeficiency prompted a number of lower respiratory tract infections (including AIDS-related pneumocystosis), beginning in 1997 through 2000. Despite an ameliorated compliance with highly active antiretroviral therapy (HAART), which was started in 1997, during 2003, our patient experienced another hospitalization due to disseminated atypical mycobacteriosis (due to Mycobacterium avium-complex), which occurred when his CD4 lymphocyte count was 275 cells/µL and his viremia accounted for 2725 HIV-RNA copies/mL. A Helicobacter pylori-positive gastritis was also detected and cured in this occasion.
Around 18 months ago, after the appearance of a prominent right laterocervical lymphadenopathy (with a maximum diameter above 3.5 cm at ultrasonographic study), a local biopsy allowed histopathologic studies, which disclosed a polymorphous B-cell, EBV-associated lymphoproliferative disorder ( Figure 1 ) as confirmed with molecular technology. A contrast-enhanced computerized tomography (CT) of the head, neck, thorax, and abdomen demonstrated a rapidly growing proliferative tissue predominantly located at the right nasopharyngeal side, associated with bilateral, multiple laterocervical and axillary pathologic lymphadenopathies (with a maximum diameter of around 1 cm). The study of peripheral lymphocyte subsets did not show pathological immunophenotypes, but it only confirmed a worsened HIV-related immunodeficiency (as expressed by a CD4 count of 115 cells/µL). Since a malignant nasopharingeal lesion was highly suspected on the ground of clinical presentation and CT findings, multiple local biopsies were obtained, and histopathological studies disclosed an undifferentiated nasopharyngeal carcinoma, resulting positive for EBV at biomolecular assays (Figures 2 through 4 ). Anti-EBV serology testing was highly positive for overall IgG antibodies, and elevated (1:320) anti-VCA titers were also detected.
Therefore, our patient received a treatment including 10 cytotoxic chemotherapy cycles (of 2 consecutive days each), based on IV cysplatinum (30 mg per square meter/day), fluorouracil (50 mg per square meter/day), bleomycin 15 mg/day, plus folinic acid supplementation (100 mg per square meter/day), which were favorably tolerated and led to a remission of malignant disease, as established on the ground of a contrast-enhanced CT scan of the head, neck, and thorax, repeated 8 months later, which demonstrated complete disappearance of nasopharyngeal lesions and ilar-mediastinal localizations while right laterocervical lymphadenopathy persisted with an added central, necrotic component. At a subsequent CT control carried out 4 months later (12 months after the first disease recognition), some sparse hypodense areas seemed to involve the superficial left nasopharyngeal surface and the postero-lateral pharyngeal side, while parapharyngeal and paravertebral hypodense infiltrates became evident bilaterally. The clinical examination confirmed our suspicion of a local disease relapse, so our patient immediately underwent a radiotherapy cycle based on 10 subsequent applications. The HAART regimen was continued with favorable tolerability and adherence levels during the entire follow-up, but at the time of neoplastic recurrence, HIV viremia showed a value of 5320 copies/mL, while the immune recovery remained limited to 83 CD4 lymphocyte cells/µL (13% of overall T-lymphocytes). A complete disease remission has been achieved 1 month after the end of radiotherapy, and it is currently maintained up to the present 10-month follow-up, as ascertained by repeated clinical and imaging controls, including positron emission tomography (PET).
Discussion
The diagnosis of nasopharyngeal carcinoma is based on a maintained high-level clinical suspicion and is obtained with clinical (ear, nose, and throat) and fiberoptic examination, and appropriate radiological imaging: CT and magnetic resonance imaging scans are complementary for the initial screening, whereas PET technique proves more effective for the clinical follow-up and the early detection of eventual relapses. 6, 12 However, a prompt local biopsy is mandatory to examine the histopathologic picture and to J INT ASSOC PHYSICIANS AIDS CARE 6(4); 2007 study eventual cell transformation, 5, [12] [13] [14] [15] as well as to detect the presence of EBV genoma, 1,6,10,12 as mentioned above. In an immunocompromised host or among HIV-infected patients, the differential diagnosis of nasopharyngeal carcinoma has to take into account a broad spectrum of bacterial, fungal, mycobacterial, and other opportunistic infections, and lymphoma and other malignancies too, 12, 16, 17 while a concomitant, EBV-associated lymphatic hypertrophy of surrounding tissues may be more frequent just in patients with HIV disease, to mimic a lymphoproliferative disease. 17 Castleman's syndrome, initially associated with EBV too, includes multicenter proliferative disorders that seem to be more frequently associated with other herpes viruses (ie, HHV-8). 18 In fact, among HIVinfected patients, EBV-associated lymphoproliferative disorders and malignant lymphomas are known to be proportionally more frequent than in the general population, 1, 5, [13] [14] [15] but a diagnosis of AIDS may be posed only when Burkitt lymphoma or primary brain lymphoma are of concern. In about one half of AIDSrelated non-Hodgkin lymphomas, the expression of EBV antigen may be found by a wide range of histopathological studies, thus resembling the situation of African Burkitt lymphoma. 5 The histopathological classification of nasopharyngeal carcinoma may be based on 3 different aspects of malignant, squamous epithelial cells 7,14 : (1) a well-differentiated squamous carcinoma with remaining intercellular bridges and/or cheratinization; (2) a noncheratinizing carcinoma; (3) an undifferentiated carcinoma with predominant lymphocytoid infiltrate, which may be so extensive to raise the suspect of a local lymphoma, although the predominant T-lymphocyte population does not include malignant cells. In our case, the squamous cell carcinoma was associated with a bulking B-cell lymphoid infiltrate, and the lymphoid component proved CD20-positive, as a sign of extensive B-cell subset involvement by EBV infection, while the epithelial component was positive to cytocheratine search, as a marker of epithelial cells.
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To the best of our knowledge, until now we are aware of a very small number of described episodes of nasopharyngeal carcinoma in patients with HIV disease, 16, 19, 20 with only one case interesting an adult and described as a single anecdotal literature report. 19 The first described case of a very aggressive and lethal nasopharyngeal carcinoma was detected in 1993 in an adult patient who was not aware of his HIV seropositivity and could not take advantage of HAART. 19 Surprisingly, HIV-associated nasopharyngeal carcinoma apparently seems more frequent among children 16, 20 : 2 recent cases interesting the paranasal sinuses were cured with combination systemic and intrathecal chemotherapy, after a cumbersome diagnostic workup. 16 Furthermore, childhood cancers detected in Zambia showed an increase of nasopharyngeal carcinoma compared with a drop of Burkitt lymphoma, when comparing 2 periods preceding and following the HIV epidemic, respectively, all examined before the introduction of HAART. 20 As known, patients with HIV disease are also prone to develop both lymphoid hyperplasia and malignant lymphomas sharing the same location, 5, [13] [14] [15] and probably to suffer from a worse prognosis compared with that of the general population. 21 Although lymphoid hyperplasia is largely predominant in frequency, 5, 13, 15 it may usually mimic cancer and make the differential diagnosis more complicated. 5, 15 However, a malignant transformation of a nasopharyngeal lymphoid hyperplasia longitudinally followed over a long period of time has been demonstrated, 14 suggesting that the boundaries between these 2 conditions are not so distant.
A 2005 observation pointed out the pattern of expression of the chemokine receptor CXCR4 in nasopharyngeal carcinoma, which seems to be involved in the disease progression and may be used as a prognostic factor of this neoplastic disease 22 : A very intriguing insight of the 2005 study also comes from the well-recognized role of the CXCR4 membrane ligand as a coreceptor for HIV virus, although the intrinsically low frequency of squamous nasopharyngeal carcinoma in HIV-infected patients does not seem to be related to a direct oncogenic role of HIV itself (or isolated HIV infection). As a matter of fact, the pathogenetic role of either EBV or HIV in the rare episodes of HIV-associated nasopharyngeal carcinoma has to be elucidated.
From a therapeutic point of view, both chemotherapy and radiotherapy significantly increased the survival of patients with nasopharyngeal carcinoma, although depending on the disease stage at the time of recognition. Early recurrence detection, and eventual surgical salvage procedures, may act on survival rate and duration when either nasopharyngeal squamous cell carcinoma or lymphoma are of concern. 2,6,7 On the other hand, a specific treatment for EBV disease (as a frequent triggering event of both neoplasms) is not available, although virus-associated complications may be treated with various types of immune modulation techniques, including adoptive therapy conducted through infusion of human leukocyte-associated antigenmatched EBV cytotoxic T cells, or possibly a vaccine based on the structural antigen pg350. 2, 3, 5, 23 Moreover, increasing problems should be taken into account when HIV-infected patients are of concern, with special attention devoted to the role of antiretroviral therapy and tolerability issues of cytotoxic and radiant therapy.
In conclusion, our patient suffered from 2 distinct malignant and premalignant conditions that are possibly connected in some of their pathogenetic pathways (although this hypothesis may only stimulate further investigation in this field). Both the malignant nasopharyngeal squamous cell carcinoma and the concurrent preneoplastic B-cell lymphoproliferative disorder (which shows a greater frequency just in the immunocompromised host, like organ transplant recipients and HIV-infected patients, who cannot mount an efficient immune response against the tumor) may share similar biomolecular triggers when an underlying active EBV infection is present, as also demonstrated by elevated serum anti-VCA antibodies. On the other hand, the accompanying T-lymphocyte infiltrate often associated to nasopharyngeal carcinoma was negligible or absent in our case, probably due to the concurrent HIV-related profound immunodeficiency leading to a low peripheral T-cell count, and the overwhelming local B-cell proliferation, which has also been demonstrated to have the possibility to drive toward a malignant, local lymphoid disease. 5, 14 In fact, the EBV-infected and transformed infiltrating CD20 B-lymphocytes might play a role in the development of the squamous cell carcinoma 6 or may lead to a true malignant lymphoma. 14 Moreover, in our case, the chronic exposure to inhalating drugs and tobacco could have represented an additional risk factor for nasopharyngeal tumor development, 24 possibly comparable to those detected in patients exposed to environmental carcinogenic substances in selected geographic areas, 6, 7 although these are not literature evidences of a connection between specific inhaled abuse substances (ie, cocaine, in our case) and nasopharyngeal malignancies. The intricate epidemiological and pathogenetic scenario focused on by our unusual case report should deserve further systematic investigation to clarify the frequency of the association among nasopharyngeal carcinoma, local B-cell lymphoid proliferation, and concurrent HIV and EBV infection and the respective role played by all these conditions. Adequate population studies will also help to avoid missed or delayed diagnosis and to trace the natural history of both disorders when HIV disease and/or cell-mediated immunodeficiency are of concern.
